企業プロフィール
ALXN 株価・ニュース・カタリスト
- ティッカー:
- ALXN
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価変動の要因
Current closing-price context is not available for ALXN.
企業概要
事業概要
Alexion Pharmaceuticals was a rare-disease biotechnology company known for complement biology and ultra-rare disease therapies before being acquired by AstraZeneca. Its business centered on high-value specialty medicines for severe, uncommon conditions.
所在地とセクター分類
Alexion was headquartered in the United States and listed on NASDAQ before its acquisition. It occupied a rare-disease biopharma position with global commercial reach.
ビジネスモデルの特徴
The company relied on specialty drug commercialization, rare-disease access, and the durability of high-value orphan therapies. Investors historically watched launch performance, label breadth, and the sustainability of its rare-disease franchise.
バイオ業界での位置付け
Alexion was a premium rare-disease biotech name with a strong commercial identity. It stood out because of its orphan-drug focus and the way a narrow portfolio could still create a large market value.
今後のカタリスト
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。